World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
62
Citations
12638
World Ranking
2986
National Ranking
12

Raymond L. Stallings publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Raymond L. Stallings sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 196 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Raymond L. Stallings D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Raymond L. Stallings sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 62 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Raymond L. Stallings is affiliated with the Royal College of Surgeons in Ireland. Their research primarily spans the domains of Medicine and Biochemistry, Genetics, and Molecular Biology, with notable contributions across related subfields including Molecular Biology, Neurology, Surgery, Cell Biology, and Pulmonary and Respiratory Medicine.

The scientist's work has concentrated significantly on Neuroblastoma Research and Treatments, addressing various biological processes relevant to clinical oncology. Additional main topics of study include Signaling Pathways in Disease, Mechanisms of Cancer Metastasis, Polyamine Metabolism and Applications, Pancreatic Function and Diabetes, Cellular Mechanics and Interactions, and Sarcoma Diagnosis and Treatment.

Recent publications highlight an interest in molecular and cellular mechanisms underpinning cancer and disease progression. Noteworthy papers include:

  • "A Context-Dependent Role for MiR-124-3p on Cell Phenotype, Viability and Chemosensitivity in Neuroblastoma in vitro" (2020) published in Frontiers in Cell and Developmental Biology
  • "A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma" (2021) published in Cancers
  • "Correction: Metastasis Suppressor microRNA-335 Targets the Formin Family of Actin Nucleators" (2023) published in PLoS ONE

These publications reflect the integration of molecular biology techniques with clinical oncology topics, particularly focusing on genetic and cellular factors influencing neuroblastoma and cancer metastasis.

Stallings frequently collaborates with a number of coauthors. Regular collaborators include:

  • Olga Piskareva
  • Ellen King
  • Nadiya Bayeva
  • John Nolan
  • Manuela Salvucci

The venues in which Stallings has published are specialized journals featuring molecular and cellular biology, oncology, and clinical research. These include Frontiers in Cell and Developmental Biology, Cancers, and PLoS ONE.

Best Publications

  • MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.

    C Welch;Y Chen;R L Stallings

  • Evolution and distribution of (GT)n repetitive sequences in mammalian genomes

    R.L. Stallings;A.F. Ford;D. Nelson;D.C. Torney

  • Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects

    Eva M Jimenez-Mateos;Tobias Engel;Paula Merino-Serrais;Ross C McKiernan

  • Differential Patterns of MicroRNA Expression in Neuroblastoma Are Correlated with Prognosis, Differentiation, and Apoptosis

    Yongxin Chen;Raymond L. Stallings

  • LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression

    Jan J Molenaar;Raquel Domingo-Fernández;Marli E Ebus;Sven Lindner

  • Analysis of chromosome breakpoints in neuroblastoma at sub‐kilobase resolution using fine‐tiling oligonucleotide array CGH

    Rebecca R. Selzer;Todd A. Richmond;Nathan J. Pofahl;Roland D. Green

  • Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes.

    Erin L. Heinzen;Rodney A. Radtke;Thomas J. Urban;Gianpiero L. Cavalleri

  • Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles.

    Amanda Tivnan;Amanda Tivnan;Wayne Shannon Orr;Wayne Shannon Orr;Vladimir Gubala;Robert Nooney

  • Human metallothionein genes: structure of the functional locus at 16q13.

    A.K. West;R. Stallings;C.E. Hildebrand;R. Chiu

  • miRNA Expression Profile after Status Epilepticus and Hippocampal Neuroprotection by Targeting miR-132

    Eva M. Jimenez-Mateos;Isabella Bray;Amaya Sanz-Rodriguez;Tobias Engel

  • miR-126 Is Downregulated in Cystic Fibrosis Airway Epithelial Cells and Regulates TOM1 Expression

    Irene K. Oglesby;Isabella M. Bray;Sanjay H. Chotirmall;Raymond L. Stallings

  • Unequivocal Delineation of Clinicogenetic Subgroups and Development of a New Model for Improved Outcome Prediction in Neuroblastoma

    Jo Vandesompele;Michael Baudis;Katleen De Preter;Nadine Van Roy

  • Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes

    Katleen De Preter;Jo Vandesompele;Pierre Heimann;Nurten Yigit

  • The sequence and analysis of duplication-rich human chromosome 16

    Joel Martin;Cliff Han;Laurie A. Gordon;Astrid Terry

  • Physical mapping of human chromosomes by repetitive sequence fingerprinting.

    Raymond L. Stallings;David C. Torney;Carl E. Hildebrand;Jonathan L. Longmire

  • Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy

    Suzanne F.C. Miller-Delaney;Kenneth Bryan;Sudipto Das;Ross C. McKiernan

  • MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2.

    Niamh H. Foley;Niamh H. Foley;Isabella M. Bray;Isabella M. Bray;Amanda Tivnan;Amanda Tivnan;Kenneth Bryan;Kenneth Bryan

  • MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway

    Jennifer Lynch;Joanna Fay;Joanna Fay;Maria Meehan;Maria Meehan;Kenneth Bryan;Kenneth Bryan

  • MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2.

    N H Foley;I Bray;I Bray;K M Watters;K M Watters;S Das;S Das

  • MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma.

    Amanda Tivnan;Amanda Tivnan;Lorraine Tracey;Patrick G Buckley;Patrick G Buckley;Leah C Alcock;Leah C Alcock

Frequent Co-Authors

Jo Vandesompele
Jo Vandesompele Ghent University
Johannes H. Schulte
Johannes H. Schulte Charité - University Medicine Berlin
Katleen De Preter
Katleen De Preter Ghent University
Rogier Versteeg
Rogier Versteeg University of Amsterdam
Michael J. Siciliano
Michael J. Siciliano The University of Texas MD Anderson Cancer Center
Norman A. Doggett
Norman A. Doggett Los Alamos National Laboratory
David F. Callen
David F. Callen University of Adelaide
Franki Speleman
Franki Speleman Ghent University
Jan Koster
Jan Koster University of Amsterdam
Genevieve Laureys
Genevieve Laureys Ghent University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring genetics can open doors to diverse careers within healthcare and research. A strong foundation in genetics often complements allied health professions, many of which now offer flexible and affordable online pathways.

For those interested in direct patient care, you may consider shortest lpn program options for a faster entry into healthcare. Alternatively, students who wish to bypass standardized testing can look into nursing schools that don't require teas, creating additional accessibility.

Looking to move into healthcare management? Pursuing one of the cheapest mha programs online healthcare can pave the way towards leadership roles in hospital or laboratory settings. For advanced practice or research, check out the cheapest online nursing phd programs for doctoral studies.

These options allow genetics students to tailor their educational journey—aligning career goals with flexible, affordable online learning opportunities.

Best Scientists Citing Raymond L. Stallings

Trending Scientists

Recently Published Articles